Nephrocare Health IPO Date, Review, Price, Allotment Details IPO
Nephrocare Health IPO Summary
IPO Open Date: 10 Dec 2025
IPO Close Date: 12 Dec 2025
Price Band: ₹438 to ₹460 Per Share
Issue Size: Approx ₹871.05 Crores
Listing Exchange: BSE NSE
Website: http://www.nephroplus.com/
Nephrocare Health IPO Overview
Nephrocare Health IPO open date is December 10, 2025 and the IPO will close on December 12, 2025. Nephrocare Health IPO is a Book Built Issue. The company to raise around ₹871.05 crores via IPO that comprises fresh issue of ₹353.40 crores and offer for sale up to 1,12,53,102 equity shares with face value of ₹2 each.
Nephrocare Health IPO price band is ₹438 to ₹460 per share. The retail quota is 35%, QIB is 50%, and HNI is 15%. Nephrocare Health IPO to list on BSE, NSE on December 17, 2025. The allotment of Nephrocare Health IPO date is December 15, 2025.
The company reported revenue of ₹769.92 crores in 2025 against ₹574.72 crores in 2024. The company reported profit of ₹67.10 crores in 2025 against profit of ₹35.13 crores in 2024. As per the financials the IPO investors should apply the IPO for a long term.
Nephrocare Health IPO Details
| Company Name | Nephrocare Health Services Ltd. |
| IPO Open Date | 10 Dec 2025 |
| IPO Close Date | 12 Dec 2025 |
| Face Value | ₹2 Per Equity Share |
| Price Band | ₹438 to ₹460 Per Share |
| Issue Size | Approx ₹871.05 Crores |
| Fresh Issue | Approx ₹353.40 Crores |
| Offer for Sale | Approx 1,12,53,102 Equity Shares |
| Issue Type | Book Built Issue |
| Listing On | BSE, NSE |
Nephrocare Health IPO Review & Key Points
May Apply
Nephrocare Health IPO Market Lot
The Nephrocare Health IPO minimum market lot is 32 shares with ₹14,720 application amount. The retail investors can apply up-to 13 lots with 416 shares of ₹1,91,360 amount.
| Category | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 | 32 | ₹14,720 |
| Retail Maximum | 13 | 416 | ₹1,91,360 |
| S-HNI Minimum | 14 | 448 | ₹2,06,080 |
| S-HNI Maximum | 67 | 2,144 | ₹9,86,240 |
| B-HNI Minimum | 68 | 2,176 | ₹10,00,960 |
Nephrocare Health IPO Reservation
| Investor Category | Shares Offered | % of Issue |
|---|---|---|
| Anchor Investor | 56,57,919 Shares | -% |
| QIB (Ex. Anchor) | – Shares | 50% |
| NII / HNI | – Shares | 15% |
| Retail | – Shares | 35% |
Anchor Bidding Date: 09 Dec 2025
Anchor Issue Size: 260.26 Cr.
30 Days Lock-in: 14 Jan 2026
90 Days Lock-in: 15 Mar 2026
Nephrocare Health IPO Dates & Allotment
| IPO Opening Date | 10 Dec 2025 |
| IPO Closing Date | 12 Dec 2025 |
| Bidding Cutoff Time | 5 PM |
| Basis of Allotment | 15 Dec 2025 |
| Refunds Initiation | 16 Dec 2025 |
| Credit to Demat | 16 Dec 2025 |
| IPO Listing Date | 17 Dec 2025 |
Nephrocare Health IPO Objects of the Issue & Utilization of Proceeds
| Description | Amount |
|---|---|
| Capital expenditure by the Company for opening new dialysis clinics in India and | ₹129.11 |
| Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by the Company | ₹136 |
| General corporate purposes | ₹- |
Nephrocare Health Services Ltd. Financials
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2023 | ₹443.26 | ₹451.85 | ₹11.79 | ₹666.23 |
| 2024 | ₹574.72 | ₹541.56 | ₹35.13 | ₹806.02 |
| 2025 | ₹769.92 | ₹682.48 | ₹67.10 | ₹996.46 |
| September 2025 | ₹483.97 | ₹456.07 | ₹14.23 | ₹1,193.68 |
Nephrocare Health IPO Valuation
Check Nephrocare Health IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Parameter | Value |
|---|---|
| Earnings Per Share (EPS) | ₹8.28 (Basic) |
| P/E Ratio | N/A |
| Return on Equity (ROE) | 13.45% |
| Return on Capital Employed (ROCE) | -% |
| Return on Net Worth (RoNW) | 13.19% |
| Net Asset Value (NAV) | ₹59.56 |
| EBITDA Margin | 22.05% |
| PAT Margin | 8.88% |
| Debt to Equity Ratio | 0.58 |
Nephrocare Health IPO Peer Group Comparison
| Company | EPS | P/E | RoNW % | NAV | Total Income |
|---|---|---|---|---|---|
| Narayana Health | 38.90 | 50.62 | NA | NA | 5,482.98 Cr. |
| Jupiter Life Line Hospitals | 29.47 | 51.27 | 14.27% | 192.55 | 1,261.55 Cr. |
| Rainbow Children Hospital | 23.97 | 64.00 | 16.56% | 134.67 | 1,515.87 Cr. |
| Dr. Agarwal’s Healthcare | 2.80 | 155.32 | NA | NA | 1,711 Cr. |
| Vijaya Diagnostics | 13.95 | 73.20 | NA | NA | 681.39 Cr. |
| Dr. Lal Path Labs | 58.48 | 50.75 | 22.30% | 244.39 | 2,461.40 Cr. |
| Metropolis Healthcare | 28.29 | 73.10 | NA | NA | 1,331.20 Cr. |
Nephrocare Health IPO Promoters & Holding Pattern
The promoters of the company are Vikram Vuppala, Bessemer Venture Partners Trust, Edoras Investment Holdings Pte. Ltd., Healthcare Parent Limited, Investcorp Private Equity Fund Ii And Investcorp Growth Opportunity Fund.
| Particulars | Shares | % Share |
|---|---|---|
| Promoter Holding Pre Issue | 9,26,50,799 | 78.90% |
| Promoter Holding Post Issue | 10,03,33,516 | 71.49% |
Nephrocare Health IPO Lead Managers (Merchant Bankers)
- ICICI Securities Ltd.
- Ambit Pvt.Ltd.
- IIFL Capital Services Ltd.
- Nomura Financial Advisory & Securities (India) Pvt.Ltd.
About Nephrocare Health Services Ltd.
Nephrocare Health Services (also known as NephroPlus) is a leading Indian dialysis provider offering comprehensive kidney care, including hemodialysis, home/mobile dialysis, diagnostics, and wellness, operating a vast network of clinics across India (especially Tier II/III cities) and internationally in countries like the Philippines, Uzbekistan, and Nepal, known for its significant scale, PPP models, and strong hospital partnerships, currently going through an Initial Public Offering (IPO) to fund further expansion and debt reduction
Nephrocare Health Services Ltd. Address
Hyderabad, Telangana, 500081Phone: +91 40 4240 8039
Nephrocare Health IPO Registrar
Kfin Technologies Ltd.
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://ipostatus.kfintech.com/